Takeda Reports Positive Data From Phase 4 Entyvio Trial
Takeda said the VERDICT trial evaluated Entyvio in ulcerative colitis and related complications.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Takeda said the VERDICT trial evaluated Entyvio in ulcerative colitis and related complications.